Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 Selectivity
Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
Authors: Mark E. Schnute, Huixian Wu, John I. Trujillo, Wei Li, David Jonathan Wasilko, Jennifer Alley, Eric P. Arnold, Scott W. Bagley, Gabriel Berstein, David C. Blakemore, Mark W. Bundesmann, Gary M. Chinigo, Chulho Choi, Robert Cooke, Kimberly Crouse, Alpay Dermenci, Theresa Dickinson, Andrew Flick, Richard K. Frisbie, Carmen Garcia-Irizarry, Brian S. Gerstenberger, David Hepworth, Neelu Kaila, Daniel W. Kung, Daniel Lamb, Sophie Y. Lavergne, David C. Limburg, Shenping Liu, Vincent M. Lombardo, Prolay K. Mondal, James J. Mousseau, Arjun Narayanan, Nootaree Niljianskul, Philippe Nuhant, Senliang Pan, Michael J. Primiano, Mathieu Rappas, Daniel C. Schmitt, Stefanus J. Steyn, Ray Unwalla, Dipy Vasa, Michael L. Vazquez, Fabien Vincent, Xiaojing Yang, Atli Thorarensen
Institution: Pfizer (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414393280